In the matter of Supriya Pharmaceuticals Limited Cp No. (Ib)- 74-9-JPR-2021
Case brief
What is this about?
NCLT admitted an application for initiating CIRP against M/s Supriya Pharmaceuticals Limited. The court held the claim was within limitation despite SICA bar, found no pre-existing dispute on the admitted operational debt, and appointed the proposed IRP.
What did the court decide?
CP No. (IB)-74/9/JPR/2021 was admitted; moratorium invoked under Section 14; M/s Sanjeet Kumar Sharma appointed as IRP.